CAT and pemphigus foliaceus: Considering that CAT did not harm the liver during this study and that there have been previous studies on CAT in combination with other compounds to reduce drug-induced hepatitis, further research should focus on clinically evaluating the effectiveness and side-effects of CAT in patients with PF.